R Brad Jones is a viral immunologist and Associate Professor at Weill Cornell Medicine in the Division of Infectious Diseases. His current research is focused on understanding how to effectively harness innate and adaptive cellular immune responses to contribute to the elimination of the HIV reservoirs that persist in individuals on long-term therapy, and thus to inform efforts to cure infection. Work in the Jones lab has led to the discovery of cell-intrinsic resistance to cytotoxic T-cells as a contributor to HIV persistence on long-term antiretroviral therapy, with ongoing research focused on uncovering and overcoming underlying mechanisms. Dr Jones received his PhD in immunology from the University of Toronto before beginning a postdoctoral fellowship at the Ragon Institute of MGH, MIT, and Harvard in 2012. He currently serves as a principal investigator of the NIH-funded Martin Delaney BELIEVE Collaboratory.